We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+0.41%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.98%
AUM
$241B
AUM Growth
+$7.57B
Cap. Flow
+$8.13B
Cap. Flow %
3.37%
Top 10 Hldgs %
21.84%
Holding
2,809
New
56
Increased
1,358
Reduced
887
Closed
62

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$948M
2
SNOW icon
Snowflake
SNOW
+$542M
3
SE icon
Sea Limited
SE
+$501M
4
PG icon
Procter & Gamble
PG
+$491M
5
SNAP icon
Snap
SNAP
+$403M

Sector Composition

Rank Sector Weight
1 Technology 26.21%
2 Healthcare 13.25%
3 Financials 13.07%
4 Consumer Discretionary 12.28%
5 Communication Services 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AYI icon
801
Acuity Brands
AYI
$10.8B
$21.5M 0.01%
123,751
+8,478
+7% +$1.49M
RPRX icon
802
Royalty Pharma
RPRX
$25.3B
$21.3M 0.01%
590,139
+16,704
+3% +$649K
FATE icon
803
Fate Therapeutics
FATE
$326M
$21.3M 0.01%
359,409
+15,842
+5% +$1.24M
EXP icon
804
Eagle Materials
EXP
$6.57B
$21.3M 0.01%
162,057
-11,327
-7% -$1.63M
NEO icon
805
NeoGenomics
NEO
$2.13B
$21.1M 0.01%
438,096
-10,305
-2% -$477K
EVBG
806
DELISTED
Everbridge, Inc. Common Stock
EVBG
$21M 0.01%
139,133
-2,841
-2% -$421K
CLVT icon
807
Clarivate
CLVT
$1.16B
$20.9M 0.01%
955,152
-2,880
-0.3% -$70.1K
PLAY icon
808
Dave & Buster's
PLAY
$357M
$20.9M 0.01%
544,452
-10,007
-2% -$362K
IGMS
809
DELISTED
IGM Biosciences
IGMS
$20.8M 0.01%
315,967
-19,612
-6% -$1.5M
MGNI icon
810
Magnite
MGNI
$3.55B
$20.8M 0.01%
741,194
-17,328
-2% -$521K
JBGS
811
JBG SMITH
JBGS
$708M
$20.7M 0.01%
698,671
+2,206
+0.3% +$68.1K
GRP.U
812
DELISTED
Granite Real Estate Investment Trust
GRP.U
$20.7M 0.01%
290,843
+18,392
+7% +$1.3M
VBTX
813
DELISTED
Veritex Holdings
VBTX
$20.6M 0.01%
522,914
-6,935
-1% -$242K
LNW
814
DELISTED
Light & Wonder
LNW
$20.4M 0.01%
245,924
-312,037
-56% -$22M
HEI icon
815
HEICO Corp
HEI
$51.4B
$20.4M 0.01%
154,612
+3,266
+2% +$430K
RS icon
816
Reliance Steel & Aluminium
RS
$21.6B
$20.4M 0.01%
143,074
+14,408
+11% +$2.17M
SSD icon
817
Simpson Manufacturing
SSD
$8.16B
$20.4M 0.01%
190,325
-5,214
-3% -$577K
AIMC
818
DELISTED
Altra Industrial Motion Corp
AIMC
$20.3M 0.01%
367,390
-6,937
-2% -$414K
ATRC icon
819
AtriCure
ATRC
$2.11B
$20.3M 0.01%
291,516
-6,020
-2% -$463K
TRGP icon
820
Targa Resources
TRGP
$55.1B
$20.2M 0.01%
410,668
+7,457
+2% +$328K
ALKS icon
821
Alkermes
ALKS
$8.25B
$20.1M 0.01%
653,329
+112,739
+21% +$3.19M
ALXO icon
822
ALX Oncology
ALXO
$290M
$20.1M 0.01%
272,337
-3,796
-1% -$253K
CSL icon
823
Carlisle Companies
CSL
$15.4B
$20.1M 0.01%
101,081
-35,671
-26% -$7.2M
IPGP icon
824
IPG Photonics
IPGP
$3.84B
$20M 0.01%
126,365
-147,340
-54% -$27.1M
KSS icon
825
Kohl's
KSS
$2.19B
$20M 0.01%
424,634
+1,170
+0.3% +$62.5K

Similar funds

UBS AM's Q3 2021 Portfolio in Review

As of Q3 2021, UBS AM held 2,809 positions worth $241B, up 3.2% from $234B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

UBS AM deployed $8.13B of net new capital in Q3 2021, opening 56 new positions and adding to 1,358 existing holdings. Its largest new stake was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Infosys, an estimated $434M trimmed.

  • UBS AM's largest Q3 2021 buy was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
  • UBS AM added most to Microsoft in Q3 2021, an estimated $948M increase.
  • UBS AM's biggest Q3 2021 reduction was Infosys, cutting an estimated $434M.
  • UBS AM fully exited Vanguard Short-Term Treasury ETF in Q3 2021, selling an estimated $350M.
  • UBS AM's ten largest holdings make up 22% of its $241B portfolio in Q3 2021.
  • UBS AM opened 56 new positions and closed 62 in Q3 2021.
  • UBS AM's portfolio value rose 3.2% quarter-over-quarter to $241B.

Based on UBS AM's 13F filing for Q3 2021, filed 15 Nov 2021.